| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70700-271-30 | 70700-271 | HUMAN PRESCRIPTION DRUG | Deferasirox | Deferasirox | TABLET | ORAL | 20200102 | N/A | ANDA | ANDA212995 | Xiromed, LLC | DEFERASIROX | 360 mg/1 | 30 TABLET in 1 BOTTLE, PLASTIC (70700-271-30) |
| 70700-270-30 | 70700-270 | HUMAN PRESCRIPTION DRUG | Deferasirox | Deferasirox | TABLET | ORAL | 20200615 | N/A | ANDA | ANDA212995 | Xiromed, LLC | DEFERASIROX | 180 mg/1 | 30 TABLET in 1 BOTTLE, PLASTIC (70700-270-30) |
| 70700-269-30 | 70700-269 | HUMAN PRESCRIPTION DRUG | Deferasirox | Deferasirox | TABLET | ORAL | 20200102 | N/A | ANDA | ANDA212995 | Xiromed, LLC | DEFERASIROX | 90 mg/1 | 30 TABLET in 1 BOTTLE, PLASTIC (70700-269-30) |